After announcing that it will begin a formal evaluation of strategic options, Keros Therapeutics, Inc. (NASDAQ: KROS) saw a significant increase in pre-market trading, with
IMAC Holdings Inc. (IMAC) stock plunged -13.16% to $1.32 in the pre-market trading after the company reported third-quarter earnings. The most recent rating by Ascendiant
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.